SEOUL, August 24 (AJP) -South Korean health supplement maker H.PIO's shares rose Monday after the company announced plans to cancel all of its treasury shares. Its shares closed 2.64 percent higher at 2,135 won ($1.54) on the KOSDAQ.
The KOSDAQ-listed company said its board approved the cancellation of 191,003 common shares, according to a regulatory filing Monday. The cancellation is scheduled for Sept. 11.
The cancellation represents about 0.46 percent of its 41.29 million outstanding common shares. Once completed, the total will fall to about 41.10 million shares, the filing showed.
The latest move follows a larger cancellation last September, when the company cancelled 796,011 shares worth about 9 billion won ($6.5 million). This year, it also paid out about 29 percent of its earnings to shareholders as dividends.
The moves come as the health supplement maker reported solid earnings in the first half. Revenue rose 8.8 percent on year to 141.8 billion won, with operating profit reaching 7.2 billion won.
Founded in 2012, H.PIO develops, manufactures and sells health supplements. Its main brand, Denps, offers products including probiotics and vitamins and draws on a Danish-inspired approach to health and wellness.
The company expects solid performance to continue in the second half and plans to use cash generated from its operations for future investments and additional shareholder returns.
AJP Takeaways
• H.PIO shares closed 2.64 percent higher at 2,135 won on the KOSDAQ on Aug. 24, 2026, after the company announced plans to cancel all of its treasury shares.
• H.PIO will cancel 191,003 common shares on Sept. 11, 2026, reducing its total common shares from about 41.29 million to 41.10 million.
• H.PIO, founded in 2012, develops, manufactures and sells health supplements under brands including Denps, which offers products such as probiotics and vitamins.
Copyright ⓒ Aju Press All rights reserved.
